Prognostic value of CD4<sup>+</sup> in patients with Т1–2N0M0 breast cancer

Aim. To evaluate the prognostic value of CD4+ in patients with T1–2N0M0 breast cancer.Materials and methods. We performed a quantitative assessment of CD4+ T-lymphocytes in tumor stromal cells and determined the prognostic parameter using the method developed by us (patent No. RU2697709C1 dated 19.0...

Full description

Saved in:
Bibliographic Details
Main Authors: R. M. Paltuev, A. G. Kudaybergenova, V. F. Semiglazov, A. V. Komyakhov, A. I. Tseluyko
Format: Article
Language:Russian
Published: ABV-press 2023-08-01
Series:Опухоли женской репродуктивной системы
Subjects:
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/1105
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items